Datamonitor HC

@Datamonitor_HC

Datamonitor Healthcare provides timely, in-depth analysis of the pharmaceutical and biotechnology industries

Vrijeme pridruživanja: srpanj 2012.

Tweetovi

Blokirali ste korisnika/cu @Datamonitor_HC

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Datamonitor_HC

  1. prije 2 sata

    The 2019 American Society of () was held in December in Orlando & again CAR-T & were hot topics. Find out more in our report extract here

    Poništi
  2. 4. velj

    Did you miss out on ? Our report extract provides an overview of the meeting's findings from early results to updated results from key . Download yours here

    Poništi
  3. 4. velj

    This get the latest intelligence & analysis reports on & their treatments at the . Click to see more:

    Poništi
  4. 31. sij

    With the number of confirmed deaths increasing every day, what impact will the Coronavirus have?

    Poništi
  5. 31. sij

    Get expert analysis of the biggest news to come out of . Find out more in our report extract here

    Poništi
  6. 29. sij

    Get the highlights from the world's most comprehensive event of the year by downloading the post - 2019 report extract here:

    Poništi
  7. 29. sij

    Did you miss our Best Selling Drugs of 2018 report last year? Go beyond in this report that looks into what geographies are helping inflate prices & how top drugs benefit from marketing expertise. Get your copy here

    Poništi
  8. 27. sij

    Gain an insight into the debate over suitable and sustainable pricing strategies for in one of our FREE downloads here

    Poništi
  9. 24. sij

    What are the Global Market Access Trends that made 2019? Hear from our experts as they use data to examine the challenges and opportunities in . Register here to listen to this & more of our top 2019

    Poništi
  10. 24. sij

    Incidence rates of are highest in sub-Saharan Africa, Latin America & Oceania. Learn more about the 4th most common with our in-depth reports on the .

    Poništi
  11. 23. sij

    is the fourth most common type of cancer amongst women worldwide. Discover more in our in-depth and disease analysis reports on . Click here

    Poništi
  12. 23. sij

    Do you know what the top selling of 2018 were? What were the breakthroughs in cancers? Download our top 4 reports for 2019 and answer these questions & more!

    Poništi
  13. 22. sij

    What were the top trends in 2018 that influenced 2019 R&D? Discover more in our recording of the Pharma R&D Review here:

    Poništi
  14. 21. sij

    From to an insight into pricing strategies - has you covered for up-to-date reports and data. Get a glimpse into what to expect with our top 4 from 2019

    Poništi
  15. 20. sij

    From the revolution through to the & its Commissioners, get expert analysis into the industry from . Click to register to gain access to our top 2019

    Poništi
  16. 17. sij

    Working within the and industries you should be aware about how quickly opportunities change, but did you know that can keep you up to date & informed all year round? Get a sample of our indepth reports here

    Poništi
  17. 16. sij

    Listen to the top of 2019 here:

    Poništi
  18. 14. sij

    Did you miss out on some of our last year? Would you like to catch up on the insights & expert analysis covering topics that impact business development, competitive intelligence & more? Click here to register to listen to our recordings

    Poništi
  19. 9. sij

    Kick start your 2020 with key regulatory recordings from . Register here to get access to the top recordings of 2019

    Poništi
  20. proslijedio/la je Tweet

    Worldwide, remains one of the gravest threats to women's lives. We can eliminate cervical as a public health problem through: ✔️ intensified vaccination against HPV ✔️ screening ✔️ treatment

    , , i još njih 3
    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·